FWM
TARO

Focused Wealth Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Focused Wealth Management’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-33
Closed -$2K – 1132
2021
Q2 		$2K Hold
33
– – ﹤0.01% 838
2021
Q1 		$2K Hold
33
– – ﹤0.01% 833
2020
Q4 		$2K Hold
33
– – ﹤0.01% 754
2020
Q3 		$2K Hold
33
– – ﹤0.01% 711
2020
Q2 		$2K Hold
33
– – ﹤0.01% 699
2020
Q1 		$2K Hold
33
– – ﹤0.01% 635
2019
Q4 		$3K Hold
33
– – ﹤0.01% 631
2019
Q3 		$2K Hold
33
– – ﹤0.01% 647
2019
Q2 		$3K Hold
33
– – ﹤0.01% 652
2019
Q1 		$4K Hold
33
– – ﹤0.01% 583
2018
Q4 		$3K Hold
33
– – ﹤0.01% 604
2018
Q3 		$3K Hold
33
– – ﹤0.01% 575
2018
Q2 		$4K Hold
33
– – ﹤0.01% 544
2018
Q1 		$3K Hold
33
– – ﹤0.01% 610
2017
Q4 		$3K Sell
33
-33
-50% -$3.63K ﹤0.01% 599
2017
Q3 		$7K Buy
66
+33
+100% +$3.59K ﹤0.01% 483
2017
Q2 		$4K Hold
33
– – ﹤0.01% 589
2017
Q1 		$4K Hold
33
– – ﹤0.01% 576
2016
Q4 		$3K Hold
33
– – ﹤0.01% 596
2016
Q3 		$4K Hold
33
– – ﹤0.01% 560
2016
Q2 		$5K Hold
33
– – ﹤0.01% 530
2016
Q1 		$5K Sell
33
-60
-65% -$8.52K ﹤0.01% 488
2015
Q4 		$14K Hold
93
– – 0.01% 365
2015
Q3 		$13K Buy
93
+33
+55% +$4.61K 0.01% 363
2015
Q2 		$9K Sell
60
-33
-35% -$4.71K 0.01% 428
2015
Q1 		$13K Hold
93
– – 0.01% 390
2014
Q4 		$14K Hold
93
– – 0.01% 367
2014
Q3 		$14K Sell
93
-40
-30% -$6.02K 0.01% 383
2014
Q2 		$19K Hold
133
– – 0.01% 322
2014
Q1 		$15K Hold
133
– – 0.01% 338
2013
Q4 		$13K Buy
133
+33
+33% +$2.86K 0.01% 359
2013
Q3 		$8K Buy
+100
New +$6.49K 0.01% 402

Other funds holding TARO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Focused Wealth Management's TARO Position: Q3 2021 in Review

Focused Wealth Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2021, closing a stake of 33 shares — an estimated $2K sold.

Focused Wealth Management first reported a position in TARO in Q3 2013 and held it in 32 quarters. The position peaked at $19K in Q2 2014. 71 funds tracked by Wall St. Rank hold TARO as of Q3 2021.

  • Focused Wealth Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2021 after selling out during the quarter.
  • Focused Wealth Management sold 33 Taro Pharmaceutical Industries Ltd. shares in Q3 2021, an estimated $2K.
  • Focused Wealth Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 32 quarters.
  • Focused Wealth Management's Taro Pharmaceutical Industries Ltd. position peaked at $19K in Q2 2014.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2021.

Based on Focused Wealth Management's 13F filing for Q3 2021, filed 12 Oct 2021.